SCHEMBL1900987

SCHEMBL1900987

COc1ccc(CC(O)C(N)=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.61
SLC6A4 P31645 1/20 0.55
POLB P06746 1/20 0.53
CYP2C19 P33261 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
EPHX1 P07099 1/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
PARP1 P09874 1/20 0.48
PARP10 Q53GL7 1/20 0.48
PARP2 Q9UGN5 1/20 0.48
PARP4 Q9UKK3 1/20 0.48
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
HTT P42858 1/20 0.47
F2RL1 P55085 1/20 0.46
IDO1 P14902 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4456451 0.84 LDHA (0.73) LDHASLC6A4POLBCYP2C19CYP1A2
SCHEMBL13742814 0.84 LDHA (0.62) LDHASLC6A4POLBCYP2C19CYP1A2
SCHEMBL1371092 0.84 LDHA (0.73) LDHASLC6A4POLBCYP2C19CYP1A2
SCHEMBL8953524 0.84 LDHA (0.73) LDHASLC6A4POLBCYP2C19CYP1A2
SCHEMBL2817931 0.84 LDHA (0.73) LDHASLC6A4POLBCYP2C19CYP1A2
SCHEMBL1587128 0.82 LDHA (0.61) LDHASLC6A4POLBCYP2C19CYP1A2
SCHEMBL933857 0.82 LDHA (0.61) LDHASLC6A4POLBCYP2C19CYP1A2
SCHEMBL1587131 0.82 LDHA (0.61) LDHASLC6A4POLBCYP2C19CYP1A2
SCHEMBL8591433 0.82 LDHA (0.61) LDHASLC6A4POLBALDH1A1PPARG
SCHEMBL3357448 0.82 LDHA (0.61) LDHASLC6A4POLBCYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011051671-A1 AMINOPYRIDINE DERIVATIVES AS KALLIKREIN INHIBITORS VANTIA LIMITED (GB) 2011-05-05 WO disclosed
WO-2009135526-A1 ALPHA-MERCAPTO-AMIDES NOVARTIS AG (CH) 2009-11-12 WO disclosed